Results 211 to 220 of about 21,687 (316)

High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development. [PDF]

J Biol Chem
Van den Ackerveken P, Hannart C, Pamart D, Varsebroucq R, Wargnies M, Thiry O, Lurkin M, Vincent S, Chapelier M, Rommelaere G, Herzog M.   +10 more
europepmc   +1 more source

From cramming to binge‐watching: Integrating documentary‐based assessment into a pharmacology and toxicology curriculum—a qualitative study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi, Heleen van der Sijs, Floor van Rosse   +2 more
wiley   +1 more source

Capturing Land for Elephant Corridors in South India through the Conservation-Agrarian Squeeze. [PDF]

Environ Manage
Siddhartha A.
europepmc   +1 more source

The Ontology of Uncertainty Control (UCT) and Lack: How 'Nothingness' Gives Rise to Actional Volition

Choi Joonho
openalex   +1 more source

Professor Brooks on Consciousness and Volition

, 1895
E. D. Cope
openalex   +2 more sources

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Harnessing Uncertainty: Improvisation as a Model for Rapid Behavioral Expansion. [PDF]

Cogn Sci
Laroche J, D'Ausilio A.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test. [PDF]

Cancers (Basel)
Chen PH, Tsai TM, Lu TP, Lu HH, Pamart D, Kotronoulas A, Herzog M, Micallef JV, Hsu HH, Chen JS.   +9 more
europepmc   +1 more source